Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133436) titled 'A randomized controlled clinical study of botulinum toxin type A combined with digital stabilization splint for the treatment of myogenous temporomandibular disorders' on Sept. 28.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Stomatology Hospital of Guangzhou Medical University
Condition:
Myogenous temporomandibular disorders, characterized by masticatory muscle pain, chewing or clenching pain, muscle tenderness, and mandibular functional limitation
Intervention:
Combined digital stabilization occlusal splint and botulinum toxin type A group:Digital stabilization occlusal splint ...